Free Trial

Achilles Therapeutics (ACHL) Earnings Date, Estimates & Call Transcripts

Achilles Therapeutics logo
$1.48 0.00 (0.00%)
As of 03/26/2025

Achilles Therapeutics Earnings Summary

Upcoming Q3
Earnings Date
May. 6Estimated
Consensus EPS
(Aug. 14)
-$0.41
Actual EPS
(Aug. 14)
-$0.41

Achilles Therapeutics issued Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.41, which met the consensus estimate of -$0.41. With a trailing EPS of -$1.65, Achilles Therapeutics' earnings are expected to grow next year, from ($1.00) to ($0.93) per share.

Q2 2024 Earnings Resources

ACHL Upcoming Earnings

Achilles Therapeutics' next earnings date is estimated for Tuesday, May 6, 2025, based on past reporting schedules.

Get Achilles Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Achilles Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ACHL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Remove Ads

Achilles Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.00) EPS
Next Year EPS Consensus Estimate
($0.93) EPS
Remove Ads

Achilles Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2025
(Estimated)
--------
8/14/2024Q2 2024-$0.41-$0.41--$0.41--
5/8/2024Q1 2024-$0.46-$0.30+$0.16-$0.30--
4/4/2024Q4 2023--$0.46 -$0.46-$0.46--
11/13/2023Q3 2023-$0.38-$0.42 -$0.04-$0.42--
8/4/2023Q2 2023-$0.40-$0.42 -$0.02-$0.42--
5/10/2023Q1 2023-$0.41-$0.44 -$0.03-$0.44--

Achilles Therapeutics Earnings - Frequently Asked Questions

Achilles Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on ACHL's earnings history.

In the previous quarter, Achilles Therapeutics (NASDAQ:ACHL) reported ($0.41) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.41). Learn more on analysts' earnings estimate vs. ACHL's actual earnings.

Achilles Therapeutics (NASDAQ:ACHL) has a recorded net income of -$69.67 million. ACHL has generated -$1.65 earnings per share over the last four quarters.

Achilles Therapeutics's earnings are expected to grow from ($1.00) per share to ($0.93) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:ACHL) was last updated on 4/10/2025 by MarketBeat.com Staff
From Our Partners